(19)
(11) EP 1 481 697 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.07.2008 Bulletin 2008/29

(45) Mention of the grant of the patent:
21.02.2007 Bulletin 2007/08

(21) Application number: 04253209.3

(22) Date of filing: 28.05.2004
(51) International Patent Classification (IPC): 
A61M 1/00(2006.01)

(54)

Percutaneous access device

Perkutane Zugangsvorrichtung

Dispositif d'acces percutane

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 30.05.2003 US 449179

(43) Date of publication of application:
01.12.2004 Bulletin 2004/49

(60) Divisional application:
06076669.8 / 1731182

(73) Proprietor: CODMAN & SHURTLEFF INC.
Raynham, MA 02767-0350 (US)

(72) Inventor:
  • Sommerich, Rob
    Norton, MA 02866 (US)

(74) Representative: Mercer, Christopher Paul et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)


(56) References cited: : 
EP-A- 0 134 340
US-A- 4 676 782
US-A- 5 728 103
 DE-U- 20 012 624
US-A- 4 959 054
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).